Theragen Etex Co.Ltd (066700) - Net Assets

Latest as of September 2025: ₩145.00 Billion KRW ≈ $98.27 Million USD

Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has net assets worth ₩145.00 Billion KRW (≈ $98.27 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩245.25 Billion ≈ $166.20 Million USD) and total liabilities (₩100.25 Billion ≈ $67.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Theragen Etex Co.Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩145.00 Billion
% of Total Assets	59.12%
Annual Growth Rate	14.47%
5-Year Change	-65.11%
10-Year Change	89.68%
Growth Volatility	47.24

Theragen Etex Co.Ltd - Net Assets Trend (2005–2024)

This chart illustrates how Theragen Etex Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 066700 total assets for the complete picture of this company's asset base.

Annual Net Assets for Theragen Etex Co.Ltd (2005–2024)

The table below shows the annual net assets of Theragen Etex Co.Ltd from 2005 to 2024. For live valuation and market cap data, see 066700 market cap.

Year	Net Assets	Change
2024-12-31	₩130.54 Billion ≈ $88.47 Million	-14.64%
2023-12-31	₩152.93 Billion ≈ $103.64 Million	+6.50%
2022-12-31	₩143.60 Billion ≈ $97.31 Million	-35.52%
2021-12-31	₩222.70 Billion ≈ $150.92 Million	-40.47%
2020-12-31	₩374.12 Billion ≈ $253.54 Million	+175.37%
2019-12-31	₩135.86 Billion ≈ $92.07 Million	+67.90%
2018-12-31	₩80.92 Billion ≈ $54.84 Million	-6.91%
2017-12-31	₩86.93 Billion ≈ $58.91 Million	+20.55%
2016-12-31	₩72.10 Billion ≈ $48.86 Million	+4.77%
2015-12-31	₩68.82 Billion ≈ $46.64 Million	-16.06%
2014-12-31	₩82.00 Billion ≈ $55.57 Million	+2.93%
2013-12-31	₩79.67 Billion ≈ $53.99 Million	+11.00%
2012-12-31	₩71.77 Billion ≈ $48.64 Million	+27.80%
2011-12-31	₩56.16 Billion ≈ $38.06 Million	+14.16%
2010-12-31	₩49.19 Billion ≈ $33.34 Million	+8.28%
2009-12-31	₩45.43 Billion ≈ $30.79 Million	+73.38%
2008-12-31	₩26.20 Billion ≈ $17.76 Million	+41.17%
2007-12-31	₩18.56 Billion ≈ $12.58 Million	+61.50%
2006-12-31	₩11.49 Billion ≈ $7.79 Million	+14.76%
2005-12-31	₩10.01 Billion ≈ $6.79 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Theragen Etex Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1087454590000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	₩123.02 Billion	109.70%
Total Equity	₩112.15 Billion	100.00%

Theragen Etex Co.Ltd Competitors by Market Cap

The table below lists competitors of Theragen Etex Co.Ltd ranked by their market capitalization.

Company	Market Cap
GCL Global Holdings Ltd Ordinary Shares NASDAQ:GCL	$62.72 Million
IG Group Holdings PLC LSE:IGG	$62.72 Million
Highlight Communications AG XETRA:HLG	$62.76 Million
Daelim B&Co KO:005750	$62.76 Million
Minda Global Bhd KLSE:5166	$62.67 Million
JAG Bhd KLSE:0024	$62.65 Million
Herige SA PA:ALHRG	$62.64 Million
Ama Marine Public Company Limited BK:AMA	$62.63 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Theragen Etex Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 135,701,179,010 to 112,146,086,090, a change of -23,555,092,920 (-17.4%).
Net loss of 40,984,882,190 reduced equity.
Dividend payments of 99,135,600 reduced retained earnings.
Other factors increased equity by 17,528,924,870.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩-40.98 Billion	-36.55%
Dividends Paid	₩99.14 Million	-0.09%
Other Changes	₩17.53 Billion	+15.63%
Total Change	₩-	-17.36%

Book Value vs Market Value Analysis

This analysis compares Theragen Etex Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.87x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.15x to 0.87x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩2634.83	₩3035.00	x
2017-12-31	₩2908.53	₩3035.00	x
2018-12-31	₩2657.75	₩3035.00	x
2019-12-31	₩4445.60	₩3035.00	x
2020-12-31	₩11711.29	₩3035.00	x
2021-12-31	₩6958.10	₩3035.00	x
2022-12-31	₩4486.69	₩3035.00	x
2023-12-31	₩4239.95	₩3035.00	x
2024-12-31	₩3503.98	₩3035.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Theragen Etex Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -36.55%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -16.42%
• Asset Turnover: 1.05x
• Equity Multiplier: 2.11x
Recent ROE (-36.55%) is below the historical average (0.06%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	0.86%	0.46%	0.69x	2.69x	₩-3.00 Billion
2010	2.16%	1.18%	0.82x	2.22x	₩-3.46 Billion
2013	1.79%	1.46%	0.75x	1.63x	₩-6.08 Billion
2014	2.10%	1.50%	0.85x	1.65x	₩-6.02 Billion
2015	-11.87%	-8.26%	0.72x	2.00x	₩-15.05 Billion
2016	3.09%	2.20%	0.72x	1.95x	₩-4.98 Billion
2017	1.47%	1.18%	0.74x	1.67x	₩-7.42 Billion
2018	-12.63%	-8.70%	0.67x	2.16x	₩-18.31 Billion
2019	32.13%	31.61%	0.57x	1.78x	₩30.06 Billion
2020	-2.40%	-6.27%	0.27x	1.43x	₩-46.38 Billion
2021	-5.32%	-7.12%	0.48x	1.57x	₩-34.12 Billion
2022	6.66%	5.01%	0.77x	1.72x	₩-4.80 Billion
2023	19.32%	12.11%	0.89x	1.79x	₩12.64 Billion
2024	-36.55%	-16.42%	1.05x	2.11x	₩-52.20 Billion

Industry Comparison

This section compares Theragen Etex Co.Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.

Industry Context

Industry: Pharmaceuticals
Average net assets among peers: $100,225,866,645
Average return on equity (ROE) among peers: 0.62%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Theragen Etex Co.Ltd (066700)	₩145.00 Billion	0.86%	0.69x	$62.68 Million
Sam Chun Dang Pharm. Co. Ltd (000250)	$298.46 Billion	-3.48%	0.37x	$6.03 Billion
DongKoo Bio&Pharma Co. Ltd (006620)	$105.33 Billion	1.93%	1.32x	$33.52 Million
NatureCell Co.Ltd (007390)	$39.48 Billion	-1.17%	0.30x	$688.81 Million
Sam-A Pharm. Co. Ltd (009300)	$110.58 Billion	8.88%	0.25x	$68.66 Million
Kyung Dong Pharmaceutical Co. Ltd (011040)	$169.03 Billion	11.15%	0.19x	$89.89 Million
WooGene B&G Co. Ltd (018620)	$29.85 Billion	-6.92%	1.60x	$13.13 Million
Oscotec Inc (039200)	$26.33 Billion	-13.85%	0.55x	$990.30 Million
EstechPharma Co. Ltd (041910)	$111.39 Billion	9.84%	0.11x	$59.21 Million
Komipharm International Co. Ltd (041960)	$76.28 Billion	-3.69%	0.60x	$380.81 Million
Eagle Veterinary Technology Co.Ltd (044960)	$35.53 Billion	3.47%	0.29x	$34.35 Million

About Theragen Etex Co.Ltd

KQ:066700 Korea Pharmaceuticals

Market Cap

$62.68 Million

₩92.49 Billion KRW

Market Cap Rank

#21005 Global

#1304 in Korea

Share Price

₩3035.00

Change (1 day)

-0.16%

52-Week Range

₩2460.00 - ₩3315.00

All Time High

₩21800.00